Trial Profile
Phase 3 study of Nalbuphine®ER in patients with uremic pruritus
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Nalbuphine (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- 09 Nov 2016 New trial record
- 13 Oct 2016 According to Trevi Therapeutics media release, this study is intended to start in 2017.